EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 11-Jul-2025 01:10 ET (11-Jul-2025 05:10 GMT/UTC)

Genomic study reveals important similarities and differences in ovarian cancer mutations across populations

Huntsman Cancer Institute
Peer-Reviewed Publication

Genomic analyses funded by the National Cancer Institute show that ovarian cancer mutations are nearly identical across populations, yet some differences emerged. This information may be relevant for treatment decisions.

Journal: Cancer Research

New avenues for treating metabolic dysfunction-associated fatty liver disease

Compuscript Ltd
Peer-Reviewed Publication

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions worldwide. This complex liver disorder ranges from simple steatosis to more severe forms, including metabolic dysfunction-associated steatohepatitis (MASH), which may progress to fibrosis, cirrhosis, and even liver cancer. The latest insights into transcription factors provide a deeper understanding of the disease’s progression and potential therapeutic interventions.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China

ELF4: A key transcription factor shaping immunity and cancer progression

Compuscript Ltd
Peer-Reviewed Publication

ELF4, a transcription factor belonging to the ETS family, has emerged as a pivotal regulator in cell differentiation, immune system function, and cancer progression. This newly published review underscores its molecular complexity and clinical significance, shedding light on its dual role in tumor suppression and oncogenesis.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, China, Basic Research Support Program of Huazhong University of Science and Technology (China)

New avenues in breast cancer treatment: The role of ubiquitin-specific proteases in programmed cell death

Compuscript Ltd
Peer-Reviewed Publication

This review highlights the critical role of ubiquitin-specific proteases (USPs) in regulating programmed cell death (PCD) in breast cancer (BC). As the most prevalent malignant tumor among women, BC remains a significant global health challenge. Despite advances in therapy, resistance to treatment and metastasis continue to pose major obstacles. This article presents a comprehensive analysis of how ubiquitination and deubiquitination processes, governed by USPs, influence various cell death pathways crucial to cancer progression and treatment response.

Journal: Genes & Diseases
Funder: University of South China Innovation Foundation For Postgraduate, Postgraduate Scientific Research Innovation Project of Hunan Province, National Natural Science Foundation of China, Clinical Medical Research “4310” Program of the University of South China

Traditional Chinese medicine unlocks new potential in treating diseases through ferroptosis regulation

Compuscript Ltd
Peer-Reviewed Publication

Innovative insights into the role of ferroptosis, a unique form of programmed cell death, are reshaping the landscape of disease treatment. This growing field highlights how Traditional Chinese Medicine (TCM) can effectively modulate ferroptosis, offering novel therapeutic approaches for various conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and organ injuries. The powerful bioactive compounds in TCM have demonstrated the ability to regulate iron metabolism, lipid peroxidation, and redox balance, positioning them as key players in advancing modern medicine.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, National Natural Science Foundation of China

Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma

Compuscript Ltd
Peer-Reviewed Publication

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which tumor-infiltrating immune cells regulate endometrial carcinoma (EC). As one of the most prevalent gynecological cancers, EC continues to challenge researchers and clinicians due to its dynamic interaction with the immune microenvironment. This comprehensive review presents crucial insights into how immune cells influence tumor progression and how immune evasion strategies enable cancer cells to thrive.

Journal: Genes & Diseases

Prostate cancer is not a death knell, study shows

University of Washington School of Medicine/UW Medicine
Peer-Reviewed Publication

“Being diagnosed with prostate cancer is not a death knell,” said Montgomery, senior author of a literature and trial review that appeared in JAMA today. Montgomery is the clinical director of Genitourinary Oncology at Fred Hutch Cancer Center and University of Washington Medical Center, and a professor of medicine and urology at the UW School of Medicine.

Journal: JAMA

Four Penn cancer researchers elected as Fellows of the AACR Academy

University of Pennsylvania School of Medicine
Grant and Award Announcement

Distinguished cancer researchers Garrett M. Brodeur, MD, Susan Domchek, MD, Stephan Grupp, MD, PhD, and Robert Vonderheide, MD, DPhil, from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center have been elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR) Academy.

Is red wine a healthier choice than white wine? Uncorking the cancer risks

Brown University
Peer-Reviewed Publication

Researchers from the Brown University School of Public Health have conducted a study that scours “the vast and often contradictory literature on the carcinogenicity of red and white wine” to assess whether this assumption holds up, and to compare the cancer risks associated with wine type.

Journal: Nutrients

New CAR-T cell therapy shows promise for hard-to-treat cancers

University of Colorado Anschutz Medical Campus
Peer-Reviewed Publication

Researchers at the University of Colorado Anschutz Medical Campus have successfully developed a supercharged iteration of CAR-T cell therapy that can enhance the effectiveness and longevity of the cells, particularly against cancer cells that are harder for prior CAR-T therapies to detect and fight.

Journal: Cancer Cell